Voya Investment Management LLC Assembly Biosciences, Inc. Transaction History

Voya Investment Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.8 - $4.56 $61,233 - $73,479	-16,114 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.33 - $6.63 $9,140 - $13,995	2,111 Added 15.08%	16,114 $74,000
Q4 2020 Feb 16, 2021	BUY	$4.87 - $17.29 $15,603 - $55,397	3,204 Added 29.67%	14,003 $85,000
Q2 2020 Aug 14, 2020	SELL	$14.57 - $23.96 $49,377 - $81,200	-3,389 Reduced 23.89%	10,799 $252,000
Q1 2020 May 15, 2020	BUY	$10.27 - $21.23 $31,734 - $65,600	3,090 Added 27.84%	14,188 $210,000
Q4 2019 Feb 14, 2020	BUY	$8.36 - $23.81 $9,145 - $26,048	1,094 Added 10.94%	11,098 $227,000
Q2 2019 Aug 14, 2019	BUY	$12.9 - $20.8 $129,051 - $208,083	10,004 New	10,004 $135,000
Q1 2019 May 15, 2019	SELL	$17.7 - $24.93 $158,928 - $223,846	-8,979 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$19.05 - $36.45 $20,383 - $39,001	1,070 Added 13.53%	8,979 $203,000
Q3 2018 Nov 14, 2018	BUY	$34.41 - $44.23 $27,287 - $35,074	793 Added 11.14%	7,909 $294,000
Q2 2018 Aug 14, 2018	BUY	$39.21 - $50.29 $5,881 - $7,543	150 Added 2.15%	7,116 $279,000
Q4 2017 Feb 14, 2018	BUY	$28.58 - $49.91 $13,003 - $22,709	455 Added 6.99%	6,966 $315,000
Q3 2017 Nov 14, 2017	BUY	$23.08 - $34.92 $150,273 - $227,364	6,511	6,511 $227,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $723M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.